𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial

✍ Scribed by Fereydoun Davatchi; Bahar Sadeghi Abdollahi; Arash Tehrani Banihashemi; Farhad Shahram; Abdolhadi Nadji; Hormoz Shams; Cheyda Chams-Davatchi

Publisher
Springer
Year
2009
Tongue
English
Weight
174 KB
Volume
19
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind trial of colchicine in Be
A double-blind trial of colchicine in Behçet's syndrome
✍ Sebahattin Yurdakul; Cem Mat; Yalçin Tüzün; Yilmaz Özyazgan; Vedat Hamuryudan; Ö 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Objective. Colchicine is a widely used treatment for Behc ¸et's syndrome, even though in a previous 6-month controlled study, it was shown to be effective only in controlling erythema nodosum and arthralgias. We reassessed the effect of colchicine in Behc ¸et's syndrome in a study conducted among a

Randomized, placebo-controlled, double-b
Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease
✍ Andrea Martinuzzi; Alexandra Liava; Enrico Trevisi; Mara Frare; Caterina Tonon; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

## Abstract McArdle's disease causes limitation in exercise capacity as well as disability, the severity of which has been associated with the angiotensin‐converting enzyme (ACE) insertion (I)/deletion (D) haplotype—patients with the genotype associated with higher ACE activity show the most severe

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease
✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s